VYNE Therapeutics Inc.

NASDAQ: VYNE · Real-Time Price · USD
0.40
-1.04 (-72.22%)
At close: Jul 30, 2025, 3:59 PM

VYNE Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
19.93M 30.62M 30.91M 42.25M
Short-Term Investments
41.59M 62.63M n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
2.26M 1.51M 2.2M 3.51M
Receivables
n/a n/a 5M 7.58M
Inventory
n/a n/a 97K 7.29M
Other Current Assets
2.92M 2.71M 240K 1.5M
Total Current Assets
64.44M 95.96M 38.27M 63.19M
Property-Plant & Equipment
206K 207K 282K 354K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
2.47M 1.72M 2.48M 3.86M
Total Assets
66.91M 97.69M 40.76M 67.05M
Account Payables
2.71M 1.66M 2.39M 6.51M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a 349K
Other Current Liabilities
2.74M 4.12M 4.59M 8.45M
Total Current Liabilities
14.82M 7.54M 9.35M 18.41M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 1.31M 211K n/a
Total Long-Term Liabilities
n/a 1.41M 211K n/a
Total Liabilities
14.82M 8.95M 9.56M 18.41M
Total Debt
99K 214K -349K 349K
Common Stock
1K 1K 1.47M 5K
Retained Earnings
-731.17M -691.34M -662.74M -639.52M
Comprehensive Income
20K 26K n/a n/a
Shareholders Equity
52.09M 88.73M 31.2M 48.64M
Total Investments
41.59M 62.63M n/a n/a